The associations between meat and fish consumption and the risk of non-alcoholic fatty liver disease (NAFLD).
FDA approves Madrigal’s Rezdiffra as the first NASH therapy – Pharmaceutical Technology
Share this article According to GlobalData analysis, Rezdiffra is expected to generate $1bn in global sales in 2027. Image Credit: BlurryMe / Shutterstock. Madrigal Pharmaceuticals’